Troglitazone in Treating Patients With Liposarcoma

NCT00003058 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: troglitazone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]